Trichomonas vaginalis, a human-infectious protozoan, can display resistance to treatment by metronidazole. A library of 3,4-dichloroaniline amides based on propanil, an herbicide, has been synthesized and screened to test susceptibility to these analogs. From this preliminary study, the most effective compound 15, inhibits growth of the organism by 66% and 69% on the two strains tested, T1 and G3, respectively
Trichomoniasis, caused by the parasitic protozoan Trichomonas vaginalis, is the most common non-vira...
Metronidazole (MTZ), the FDA-approved drug against <i>Trichomonas vaginalis</i> (TV), is being chall...
The following 8 kinds of antitrichomonal drugs were examined in vitro for growth inhibiting effect u...
Trichomonas vaginalis is a protozoan that causes the sexually-transmitted disease trichomoniasis in ...
Trichomonas vaginalis is a facultative anaerobic protozoan that causes Trichomoniasis, a sexually tr...
Trichomonas vagina/is is an anaerobic parasitic protozoan. Trichomonas is a sexually transmitted dis...
Clinical cases of metronidazole resistant Trichomonas vaginalis infections have spurred interest in ...
A series of 11 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles (2–12) has been prepared starting from 1-...
Aim: Metronidazole is the most widely used drug in trichomoniasis therapy. However, the emergence of...
Trichomoniasis, the most common non-viral STD, is caused by the protozoan Trichomonas vaginalis. The...
Trichomonas vaginalis is a facultative anaerobic protozoan that causes trichomoniasis, a sexually tr...
Twenty-two different triazoles were prepared to examine the anti-Trichomonas vaginalis structure–act...
Trichomonas vaginalis, the causative agent of trichomonosis, is the most common non-viral sexually t...
Trichomonas vaginalis is an extracellular protozoan parasite that binds to the epithelium of the hum...
Trichomonas vaginalis is a protozoal parasite that causes trichomoniasis in humans. The current FDA ...
Trichomoniasis, caused by the parasitic protozoan Trichomonas vaginalis, is the most common non-vira...
Metronidazole (MTZ), the FDA-approved drug against <i>Trichomonas vaginalis</i> (TV), is being chall...
The following 8 kinds of antitrichomonal drugs were examined in vitro for growth inhibiting effect u...
Trichomonas vaginalis is a protozoan that causes the sexually-transmitted disease trichomoniasis in ...
Trichomonas vaginalis is a facultative anaerobic protozoan that causes Trichomoniasis, a sexually tr...
Trichomonas vagina/is is an anaerobic parasitic protozoan. Trichomonas is a sexually transmitted dis...
Clinical cases of metronidazole resistant Trichomonas vaginalis infections have spurred interest in ...
A series of 11 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles (2–12) has been prepared starting from 1-...
Aim: Metronidazole is the most widely used drug in trichomoniasis therapy. However, the emergence of...
Trichomoniasis, the most common non-viral STD, is caused by the protozoan Trichomonas vaginalis. The...
Trichomonas vaginalis is a facultative anaerobic protozoan that causes trichomoniasis, a sexually tr...
Twenty-two different triazoles were prepared to examine the anti-Trichomonas vaginalis structure–act...
Trichomonas vaginalis, the causative agent of trichomonosis, is the most common non-viral sexually t...
Trichomonas vaginalis is an extracellular protozoan parasite that binds to the epithelium of the hum...
Trichomonas vaginalis is a protozoal parasite that causes trichomoniasis in humans. The current FDA ...
Trichomoniasis, caused by the parasitic protozoan Trichomonas vaginalis, is the most common non-vira...
Metronidazole (MTZ), the FDA-approved drug against <i>Trichomonas vaginalis</i> (TV), is being chall...
The following 8 kinds of antitrichomonal drugs were examined in vitro for growth inhibiting effect u...